Investigational zoster vaccine effective, safe after age 70
The herpes zoster subunit vaccine was effective and safe for adults aged 70 and older in a phase III manufacturer-sponsored clinical trial, which was reported online in the New England Journal of Medicine.
The ZOE-70 study (Zoster Efficacy Study in Adults 70 years of Age or Older) assessed an...
Source: Skin and Allergy News - Category: Dermatology Source Type: news
More News: Allergy | Allergy & Immunology | Clinical Trials | Dermatology | Herpes | Shingles (Herpes Zoster) Vaccine | Skin | Study | Vaccines | Varicella-Zoster Virus Vaccine